Brief: Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Eloxx Pharmaceuticals

01/04/2021 12:57

April 1 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS ACQUIRES ZIKANI THERAPEUTICS
    * ELOXX PHARMACEUTICALS INC - ACQUIRED ZIKANI THERAPEUTICS,
INC.
IN AN ALL-STOCK TRANSACTION
    * ELOXX PHARMACEUTICALS INC - ELOXX TO ISSUE APPROXIMATELY
7.6
MILLION SHARES TO ZIKANI STOCKHOLDERS
    * ELOXX PHARMACEUTICALS INC - SUMIT AGGARWAL, ZIKANI
PRESIDENT AND
CEO, TO LEAD COMBINED COMPANY
    * ELOXX PHARMACEUTICALS INC - EXPECTS TO FILE IND FOR FIRST
ORAL
DRUG TO TREAT PATIENTS WITH RECESSIVE DYSTROPHIC AND JUNCTIONAL
EPIDERMOLYSIS BULLOSA
    * ELOXX PHARMACEUTICALS INC - STOCKHOLDERS OF ZIKANI TO OWN
APPROXIMATELY 16 PERCENT OF COMBINED COMPANY

Source text for Eikon:  ID:nGNX1Y5D8T 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))